Skip to main content
. 2009 Mar 12;100(7):1335–1343. doi: 10.1111/j.1349-7006.2009.01159.x

Figure 1.

Figure 1

Triptolide inhibits proliferation of human mast cells bearing D816V KIT. HMC‐1.2 (a), P815 (b) and HMC‐1.1 (c) cells were exposed to increasing concentrations of triptolide for 72 h. Cell viability was measured by MTS assay and was plotted as percentage cell viability relative to the control. Triptolide dose‐response curves are shown. The error bars indicate SE.